Schizophrenia 2 C1864010
A chronic mental health disorder affecting how a person thinks, feels, and behaves. It typically emerges in late adolescence or early adulthood. Treatment involves antipsychotic medication and psychotherapy to manage symptoms and improve functioning.
Key facts at a glance
- ICD-10
- F99
- ICD-11
- 6A00.0
- Body system
- psychiatric
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Auditory hallucinations
(psychiatric)Mood changes or anxiety
(psychiatric)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Delusions (paranoid or bizarre)
(psychiatric)Disorganized speech
(psychiatric)Negative symptoms (flat affect, avolition)
(psychiatric)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Atypical antipsychotic medication
Second-generation antipsychotics are preferred as first-line pharmacotherapy for addressing positive and negative symptoms. Treatment requires individualized selection based on symptom presentation and side effect profile.
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Family psychoeducation intervention
Structured family education program teaching about illness course, treatment options, and communication strategies. Helps families develop supportive environments and recognize relapse indicators.
Additional treatment options
Electroconvulsive therapy (for treatment-resistant cases)
Bilateral or unilateral ECT may be considered for severe, treatment-resistant symptoms or acute crisis situations. Requires medical evaluation and informed consent process.
procedureSupported employment and vocational rehabilitation
Assisted placement in competitive employment with ongoing job coaching, workplace accommodations, and skills development. Focuses on gradual integration into the workforce.
complementaryClozapine registry and hematologic monitoring
For patients on clozapine, regular absolute neutrophil count monitoring per registry protocols is mandatory. Includes regular physical assessments and plasma level monitoring when indicated.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Schizophrenia 2 C1864010?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kreyenbuhl JA, Buchanan RW, Dickerson FB, Dixon LB. The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations. Schizophr Bull. 2020.
Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia. Lancet. 2022.
Morrison AP, Turkington D, Pyle M, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet Psychiatry. 2021.
Millan MJ, Fone K, Steckler T, Horovitz M. Negative symptoms of schizophrenia: Developments in the search for symptomatic treatments. Nat Rev Drug Discov. 2021.
Medication Comparisons
Compare medications used to treat Schizophrenia 2 C1864010. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy